Takehiro Izumo

InstitutionJapanese Red Cross Medical Center
AddressJapan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in August 2021
    All Publications
    Bar chart showing 56 publications over 16 distinct years, with a maximum of 11 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ito Y, Awano N, Uchiyama F, Inomata M, Kuse N, Tone M, Takada K, Fujimoto K, Muto Y, Sagisaka S, Maki K, Yamashita R, Harada A, Nishimura JI, Hayashi M, Izumo T. Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports. Intern Med. 2021 Nov 01; 60(21):3503-3506. PMID: 34433713.
      Citations:    Fields:    Translation:Humans
    2. Izumo T, Kuse N, Awano N, Tone M, Sakamoto K, Takada K, Muto Y, Fujimoto K, Saiki A, Ito Y, Matsumoto H, Inomata M. Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19. Respir Investig. 2021 Nov; 59(6):799-803. PMID: 34413006.
      Citations: 1     Fields:    Translation:Humans
    3. Izumo T, Kuse N, Awano N, Tone M, Sakamoto K, Takada K, Muto Y, Fujimoto K, Saiki A, Ito Y, Matsumoto H, Inomata M. Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan. Respir Investig. 2021 Sep; 59(5):635-642. PMID: 34210623.
      Citations: 2     Fields:    Translation:Humans
    4. Ikeda S, Misumi T, Izumi S, Sakamoto K, Nishimura N, Ro S, Fukunaga K, Okamori S, Tachikawa N, Miyata N, Shinkai M, Shinoda M, Miyazaki Y, Iijima Y, Izumo T, Inomata M, Okamoto M, Yamaguchi T, Iwabuchi K, Masuda M, Takoi H, Oyamada Y, Fujitani S, Mineshita M, Ishii H, Nakagawa A, Yamaguchi N, Hibino M, Tsushima K, Nagai T, Ishikawa S, Ishikawa N, Kondoh Y, Yamazaki Y, Gocho K, Nishizawa T, Tsuzuku A, Yagi K, Shindo Y, Takeda Y, Yamanaka T, Ogura T. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study. Sci Rep. 2021 05 21; 11(1):10727. PMID: 34021229.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Awano N, Oyama N, Akiyama K, Inomata M, Kuse N, Tone M, Takada K, Muto Y, Fujimoto K, Akagi Y, Mawatari M, Ueda A, Kawakami J, Komatsu J, Izumo T. Anxiety, Depression, and Resilience of Healthcare Workers in Japan During the Coronavirus Disease 2019 Outbreak. Intern Med. 2020; 59(21):2693-2699. PMID: 33132305.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    6. Awano N, Inomata M, Kuse N, Tone M, Takada K, Muto Y, Fujimoto K, Akagi Y, Mawatari M, Ueda A, Izumo T. Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019. Respir Investig. 2020 Nov; 58(6):440-447. PMID: 32863199.
      Citations: 7     Fields:    Translation:Humans
    7. Abe T, Izumo T, Ueda A, Hayashi M, Ishibashi Y. Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia. CEN Case Rep. 2021 02; 10(1):42-45. PMID: 32715376.
      Citations: 2     Fields:    Translation:Humans